PJ Devereaux and associates1 state that the current situation with respect to evidence for β-
blocker therapy before surgery is similar to the situation that existed 12 years ago when …

© 2005 American Medical Association. All rights reserved. blinded trial of highly selected,
high-risk vascular patients. 5 In the second study, 6 the in-hospital incidence of MI was …

In their meta-analysis on the effects of β blockers in patients undergoing non-cardiac
surgery, Sripal Bangalore and colleagues (Dec 6, p 1962) 1 seem to disregard the important …

Recent studies suggest that β-blockers administered perioperatively may reduce the risk of
adverse cardiac events and mortality in patients who have cardiac risk factors and undergo …

To the Editor:—Kolodner et al.'s multicenter study 1 concludes that preoperative β-blocker
was significantly underutilized when compared with the current guideline recommendations …

To the Editor:—Kolodner et al.'s multicenter study1 concludes that preoperative β-blocker
was significantly underutilized when compared with the current guideline recommendations …

Background β-Blockers reduce morbidity and mortality when administered to high-risk
patients undergoing major noncardiac surgery, yet little is known about how often they are …

While I agree for the most part with the comments of Bouri et al [1] in their recent meta-
analysis of preoperative beta-blockade, I believe the answers to a number of questions are …